Acadian Asset Management LLC Macrogenics Inc Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
A detailed history of Acadian Asset Management LLC transactions in Macrogenics Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,491,703 shares of MGNX stock, worth $3.66 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,491,703
Previous 2,308,649
7.93%
Holding current value
$3.66 Million
Previous $2.92 Million
2.91%
% of portfolio
0.01%
Previous 0.01%
Shares
29 transactions
Others Institutions Holding MGNX
# of Institutions
113Shares Held
51.5MCall Options Held
55.3KPut Options Held
35.9K-
Bellevue Group Ag Kuesnacht, V89.92MShares$14.6 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY5.96MShares$8.76 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.4MShares$7.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$6.19 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$4.78 Million0.02% of portfolio
About MACROGENICS INC
- Ticker MGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,458,800
- Market Cap $90.3M
- Description
- MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...